459
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluation

Sucroferric oxyhydroxide for the treatment of hyperphosphatemia

&
Pages 1137-1148 | Received 28 Mar 2018, Accepted 18 Jun 2018, Published online: 09 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Valeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, Chiara Casuscelli, Silvia Di Carlo, Claudia Spinella, Guido Gembillo & Domenico Santoro. (2023) Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure. Expert Opinion on Pharmacotherapy 24:15, pages 1737-1746.
Read now
Michel Vallée, Jordan Weinstein, Marisa Battistella, Roxanne Papineau, Dianne Moseley & Gordon Wong. (2021) Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. International Journal of Nephrology and Renovascular Disease 14, pages 301-311.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.